Biorestorative TherapiesBRTX
13F holders, Q2 2025 (June 30)15holders +1
2new positions
0sold out
$1.67avg. 13F price*
At the end of Q2 2025, 15 institutions reported holding Biorestorative Therapies Inc. (BRTX) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($91K), Wealth Alliance, LLC ($67K) and StoneX Group Inc. ($63K).
- Company
- Biorestorative Therapies Inc.
- CUSIP
- 090655606
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $25K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 15,055 shares bought and 32,445 shares sold, net −17,390 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Geode Capital Management, LLC | 0.00% | Reduce -9.6% | 54,262 | $91K |
| Wealth Alliance, LLC | 0.01% | No change | 40,000 | $67K |
| StoneX Group Inc. | 0.00% | Reduce -26.3% | 37,744 | $63K |
| Morgan Stanley | 0.00% | Reduce -7.9% | 35,000 | $58K |
| Vanguard Group Inc. | 0.00% | No change | 29,730 | $50K |
| State Street Corp. | 0.00% | No change | 20,459 | $34K |
| Virtu Financial LLC | 0.00% | New | 12,032 | $20K |
| Newman Dignan & Sheerar, Inc. | 0.00% | No change | 11,522 | $19K |
| Raymond James Financial Inc. | 0.00% | New | 3,001 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,193 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -60.0% | 1,278 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +20.3% | 89 | $148 |
| Bank of America Corp. | 0.00% | Add +16.3% | 50 | $83 |
| UBS Group AG | 0.00% | Reduce -100.0% | 3 | $5 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 3 | $5 |
"% of holder's portfolio" is BRTX's weight in each manager's 13F, not the share of Biorestorative Therapies Inc. the manager owns.